885275-12-7 Usage
Uses
Used in Pharmaceutical Industry:
2-ISOPROPYLAMINO-NICOTINIC ACID is used as a pharmaceutical intermediate for its potential role in the development of new drugs. Its anti-inflammatory properties and potential in treating neurodegenerative diseases make it a promising candidate for further research and development.
Used in Anti-Inflammatory Applications:
2-ISOPROPYLAMINO-NICOTINIC ACID is used as an anti-inflammatory agent, which can help in reducing inflammation and associated symptoms in various conditions. Its pharmacological properties make it a potential candidate for the treatment of inflammatory disorders.
Used in Neurodegenerative Disease Treatment:
2-ISOPROPYLAMINO-NICOTINIC ACID is used as a potential therapeutic agent for the treatment of neurodegenerative diseases. Its potential to modulate neurodegenerative pathways and protect neuronal cells makes it a valuable compound for further investigation in this field.
Check Digit Verification of cas no
The CAS Registry Mumber 885275-12-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,7 and 5 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 885275-12:
(8*8)+(7*8)+(6*5)+(5*2)+(4*7)+(3*5)+(2*1)+(1*2)=207
207 % 10 = 7
So 885275-12-7 is a valid CAS Registry Number.
885275-12-7Relevant articles and documents
Substituted 1,3-Dihydro-2H-pyrrolopyridin-2-ones as Potential Antiinflammatory Agents
Ting, Pauline C.,Kaminski, James J.,Sherlock, Margaret H.,Tom, Wing C.,Lee, Joe F.,et al.
, p. 2697 - 2706 (2007/10/02)
A series of analogues based on the 1,3-dihydro-2H-pyrrolopyridin-2-one ring system have been synthesized and shown to possess oral antiinflammatory activity in both the reverse passive Arthus reaction (RPAR) pleural cavity assay in rats and in the adjuvant-induced arthritic rat model (AAR).Several members of this series additionally exhibit an inhibitory effect on the in vivo production of prostaglandin- and leukotriene-derived products or arachidonic acid metabolism although these compounds exhibit no significant inhibitory activity against the cyclooxygenase and 5-lipoxygenase enzymes in vitro.Structure-activity relationships in this series are discussed.